FDA “Breakthrough Therapy” Designations
Executive Summary
Breakthrough status was introduced in FDASIA to facilitate development and review for drugs to treat serious/life-threatening diseases where there is early evidence of a substantial improvement over existing therapies. FDA has not yet released details on the program, but 11 requests have been granted.